Pfizer Manufacturing Deutschland GmbH (testing, packaging, batch release)

The drug is intended for the treatment of adults with active rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who have not achieved an adequate response to standard therapy.

Dosage form: tablets, extended-release

ATC: L04AF01